Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Amati AM"'
Autor:
Amati AM; Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland., Moning SU; Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland., Javor S; Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland., Schär S; Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland., Deutschmann S; Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland., Reymond JL; Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland., von Ballmoos C; Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland.
Publikováno v:
ACS synthetic biology [ACS Synth Biol] 2024 Apr 19; Vol. 13 (4), pp. 1355-1364. Date of Electronic Publication: 2024 Apr 03.
Autor:
Amati AM; Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland., Graf S; Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland., Deutschmann S; Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland., Dolder N; Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland., von Ballmoos C; Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland.
Publikováno v:
Biochemical Society transactions [Biochem Soc Trans] 2020 Aug 28; Vol. 48 (4), pp. 1473-1492.
Autor:
Renner S; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research (NIBR), Basel, 4056, Switzerland. steffen.renner@novartis.com., Bergsdorf C; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research (NIBR), Basel, 4056, Switzerland., Bouhelal R; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research (NIBR), Basel, 4056, Switzerland., Koziczak-Holbro M; Musculoskeletal, NIBR, Basel, Switzerland., Amati AM; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research (NIBR), Basel, 4056, Switzerland.; Department of Chemistry & Biochemistry, University of Bern, Freiestrasse 3, 3012, Bern, Switzerland., Techer-Etienne V; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research (NIBR), Basel, 4056, Switzerland., Flotte L; Musculoskeletal, NIBR, Basel, Switzerland., Reymann N; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research (NIBR), Basel, 4056, Switzerland., Kapur K; NIBR Informatics, NIBR, Basel, Switzerland., Hoersch S; NIBR Informatics, NIBR, Basel, Switzerland., Oakeley EJ; ASI, NIBR, Basel, Switzerland., Schuffenhauer A; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research (NIBR), Basel, 4056, Switzerland., Gubler H; NIBR Informatics, NIBR, Basel, Switzerland., Lounkine E; Chemical Biology & Therapeutics, NIBR, 181 Massachusetts Avenue, Cambridge, MA, 02139, USA.; Modeling and Informatics, Merck & Co., Inc., 33 Avenue Louis Pasteur, Boston, MA, 02115, USA., Farmer P; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research (NIBR), Basel, 4056, Switzerland. pierre.farmer@novartis.com.
Publikováno v:
Scientific reports [Sci Rep] 2020 Jun 15; Vol. 10 (1), pp. 9670. Date of Electronic Publication: 2020 Jun 15.